Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

McLaren Applied Technologies and the University of Oxford have announced a new partnership that aims to improve the efficiency of patient care and optimise the treatment journey for serious conditions. 

The agreement, which was signed today at McLaren’s headquarters in Woking, will focus on three core areas: 

  • Surgical simulations and outcomes monitoring – creating programmes which advance surgeon training methods, improve patient preparation for surgery and enhance the monitoring of surgery effectiveness.
  • Clinical care optimisation – improving patient care journeys in key need areas, while reducing complications and length of stay in hospital.
  • Facilities optimisation - reviewing the management and allocation of critical medical resources (such as emergency departments) and clinical staff in order to optimise efficiency and availability.

Read more (McLaren Applied Technologies website).

Read the story on TechCrunch.

Similar stories

Government boost for digitisation and AI in pathology services

Awards and appointments Clinical Women

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.

QUOD enters partnership with Evotec

Clinical

Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.

How Oxford Medical Sciences is fighting Coronavirus

Clinical Research

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic.

Professor David Taggart presents results of the VEST III trial

Clinical Research

On Friday 4 October, Professor David Taggart from the Nuffield Department of Surgical Sciences (NDS) presented the results of the VEST III trial at the 2019 European Cardio-Thoracic Surgery annual meeting in Lisbon, Portugal.

High-profile doctors visit the Patient Safety Academy

Clinical Department Research Women

The Patient Safety Academy (PSA) at the Nuffield Department of Surgical Sciences was honoured to host two high profile British doctors and an international research leader yesterday.

Oxford host surgical research training course: BOSTiC 12-14 June 2019

Clinical Research

The 5th annual Bristol Oxford Surgical Trials Course (BOSTiC) was held in Oxford this year at Worcester College, University of Oxford. The course is primarily aimed at surgical trainees who are interested in clinical research, with an emphasis on design and conduct of randomised control trials.